UBS Group AG Acquires 432,727 Shares of Chimera Investment Corporation $CIM

UBS Group AG boosted its holdings in Chimera Investment Corporation (NYSE:CIM) by 130.7% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 763,691 shares of the real estate investment trust’s stock after acquiring an additional 432,727 shares during the quarter. UBS Group AG owned 0.92% of Chimera Investment worth $9,493,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CIM. VSM Wealth Advisory LLC increased its stake in Chimera Investment by 64.3% in the 3rd quarter. VSM Wealth Advisory LLC now owns 2,391 shares of the real estate investment trust’s stock worth $32,000 after acquiring an additional 936 shares during the last quarter. GAMMA Investing LLC increased its stake in Chimera Investment by 864.7% in the 4th quarter. GAMMA Investing LLC now owns 3,193 shares of the real estate investment trust’s stock worth $40,000 after acquiring an additional 2,862 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Chimera Investment by 92.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,140 shares of the real estate investment trust’s stock worth $99,000 after acquiring an additional 3,423 shares during the last quarter. BNP Paribas Financial Markets increased its stake in Chimera Investment by 59.2% in the 2nd quarter. BNP Paribas Financial Markets now owns 7,686 shares of the real estate investment trust’s stock worth $107,000 after acquiring an additional 2,857 shares during the last quarter. Finally, Creative Financial Designs Inc. ADV increased its stake in Chimera Investment by 450.2% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 9,166 shares of the real estate investment trust’s stock worth $121,000 after acquiring an additional 7,500 shares during the last quarter. 48.44% of the stock is currently owned by institutional investors.

Chimera Investment Price Performance

CIM opened at $13.08 on Friday. The stock has a 50-day moving average price of $13.25 and a 200-day moving average price of $12.97. Chimera Investment Corporation has a 12-month low of $11.67 and a 12-month high of $14.88. The company has a current ratio of 0.08, a quick ratio of 0.06 and a debt-to-equity ratio of 2.31. The stock has a market capitalization of $1.09 billion, a P/E ratio of -16.34 and a beta of 1.71.

Chimera Investment (NYSE:CIM) last posted its quarterly earnings data on Thursday, May 7th. The real estate investment trust reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.02. Chimera Investment had a return on equity of 9.36% and a net margin of 2.27%.The firm had revenue of $32.37 million during the quarter, compared to analysts’ expectations of $102.35 million.

Analyst Ratings Changes

CIM has been the topic of a number of research analyst reports. Weiss Ratings upgraded Chimera Investment from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Wall Street Zen upgraded Chimera Investment from a “sell” rating to a “hold” rating in a research note on Saturday. One analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $14.50.

Chimera Investment Profile

Chimera Investment Corporation (NYSE: CIM) is a publicly traded real estate investment trust that specializes in investing in residential mortgage assets. The company’s portfolio primarily consists of agency and non-agency residential mortgage-backed securities, whole loan residential mortgages and other mortgage-related assets. As a REIT, Chimera Investment aims to generate attractive risk-adjusted returns through its focus on high-quality collateral and disciplined risk management.

The firm’s core business activities include identifying and acquiring portfolios of residential mortgage loans and securities from financial institutions and in the secondary market.